Connect Sign In
ARUP experts seek to increase understanding of the FDA’s proposed rule to regulate lab-developed tests as medical devices and the impact on hospitals and patients during a webinar on November 29.
A panel discussion at the Utah Life Sciences Summit explored how the FDA’s proposed rule to further regulate laboratory-developed tests could slow advances in diagnostic medicine.
EU Approval of AAV5 DetectCDx™ Provides Access to Companion Diagnostic for Hemophilia A Gene Therapy
ARUP has gained a Conformité Européenne (CE) mark for AAV5 DetectCDx™ single-site use. The test will aid in determining the eligibility of non-U.S. patients for a new hemophilia A gene therapy.
ARUP to Highlight Molecular Pathology Advances at Annual Association for Molecular Pathology Meeting
ARUP experts in molecular pathology will present at, participate in, and be available to attendees during the upcoming Association for Molecular Pathology (AMP) Meeting and Expo in Salt Lake City.
The Association for the Advancement of Blood and Biotherapies recommends that providers use a restrictive transfusion strategy to reduce unnecessary transfusions and the risk of adverse events.
ARUP’s David P. Ng, MD, will share a presentation on artificial intelligence (AI) in the clinical lab at the Patient-centered Laboratory Utilization Guidance Services (PLUGS) Regional Summit.
During a networking event cohosted by ARUP, leaders in the life sciences advocated for more returnships to help those who have taken time off ease back into careers in STEM.
The newest edition highlights innovations that keep ARUP at the forefront of toxicology testing. Also featured: ARUP’s expanded capacity for cytogenetics testing.
ARUP Blood Services has announced the rollout of its Whole Blood Titan program, which will encourage donations of low-titer, type O blood that is vital to saving lives in emergency situations.
A platform clients use to reduce testing waste, lower cost per test, and improve patient safety has won the prestigious Choosing Wisely Champion Award from the American Society for Clinical Pathology.
ARUP Consult, a free source of expert guidance in laboratory testing, has released new resources on testing for polycystic ovary syndrome and autoimmune encephalitis.
The FDA’s newly proposed rules would regulate all in vitro diagnostic products as medical devices if enacted. ARUP believes additional FDA oversight would disrupt the diagnostic testing market.
